For a patient 15 days after total pancreatectomy who is receiving insulin glargine (Lantus) 11 units at 8 am and 16 units at 8 pm along with an IV insulin drip (hourly rates: 1, 0.5, 0, 0, 0, 1.5, 1, 0.5, 1, 1, 0.2, 1, 2, 1.5, 0.5, 0.25, 0.5, 0.5, 1, 1, 0.25, 1), what should the 8 am and 8 pm insulin glargine doses be adjusted to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Insulin Glargine Dose Adjustment Post-TPIAT

Based on the 24-hour IV insulin drip data showing a total of 18.2 units, I recommend increasing the 8 AM Lantus dose to approximately 15-16 units and the 8 PM dose to approximately 18-19 units, for a total daily basal dose of approximately 33-35 units.

Calculation Methodology

The guideline-based approach for transitioning from IV to subcutaneous insulin is clear: calculate the total 24-hour IV insulin requirement and convert 50-80% of this total to basal insulin 1.

Step 1: Calculate Total IV Insulin

  • Sum of hourly rates: 1 + 0.5 + 0 + 0 + 0 + 1.5 + 1 + 0.5 + 1 + 1 + 0.2 + 1 + 2 + 1.5 + 0.5 + 0.25 + 0.5 + 0.5 + 1 + 1 + 0.25 + 1 = 18.2 units over 22 hours
  • Extrapolated to 24 hours: approximately 19.8 units/day

Step 2: Apply Conversion Formula

Using the most widely cited Avanzini method: 50% of total IV insulin becomes basal insulin 1. Some protocols recommend 80% for basal insulin 1, but given this patient is only 15 days post-TPIAT with ongoing insulin requirements, the conservative 50% approach is safer initially.

  • Conservative calculation (50%): 19.8 × 0.5 = 9.9 units/day basal
  • Current total Lantus: 11 + 16 = 27 units/day
  • Moderate calculation (70%): 19.8 × 0.7 = 13.9 units/day basal

Step 3: Account for Current Basal Coverage

The patient is already receiving 27 units of Lantus daily PLUS requiring 18.2 units IV insulin. This indicates:

  • Total insulin need: 27 + 18.2 = 45.2 units/day
  • Recommended basal (50-80%): 22.6-36.2 units/day
  • Target basal dose: approximately 33-35 units/day

Dose Distribution Rationale

Split the total basal dose with slightly more in the evening (8 PM) than morning (8 AM) based on:

  1. Circadian insulin sensitivity patterns: Insulin sensitivity is lower during night-early morning hours in diabetic patients 2
  2. Current distribution pattern: The patient is already receiving more at 8 PM (16 units) than 8 AM (11 units), suggesting this pattern has been working
  3. Recommended split: Approximately 45% at 8 AM and 55% at 8 PM

Specific dosing:

  • 8 AM Lantus: 15-16 units (45% of 33-35 units)
  • 8 PM Lantus: 18-19 units (55% of 33-35 units)

Critical Implementation Points

Timing Considerations

  • Administer basal insulin immediately when stopping IV insulin 1. The guideline recommends 20:00 hrs (8 PM) as optimal timing for transition 1
  • Do not wait for IV insulin rate to decrease below 0.5 U/h before transitioning, as rates >3 U/h indicate insulin resistance 1

Post-TPIAT Specific Concerns

This patient has complete loss of endogenous insulin and glucagon production 3. This creates unique challenges:

  • No counterregulatory glucagon response to hypoglycemia
  • Extreme glycemic lability is expected 4
  • Higher risk of both severe hypoglycemia and ketoacidosis without any insulin 3

Monitoring Requirements

  • Blood glucose checks every 4-6 hours minimum 5
  • Target range: 80-180 mg/dL (4.4-10.0 mmol/L) perioperatively 5
  • Coefficient of variation should be <31.2% for optimal control 4
  • Immediate glucose administration for BG <60 mg/dL (3.3 mmol/L) 1

Prandial Coverage

This basal dose adjustment must be accompanied by rapid-acting insulin for meals 1:

  • Start with 1 unit per 10-15 grams of carbohydrate 5, 6
  • The remaining 50% of total daily insulin (approximately 11-13 units) should be distributed as prandial doses
  • Adjust based on carbohydrate intake and glucose response

Common Pitfalls to Avoid

  1. Do NOT mix or dilute Lantus with any other insulin or solution 7
  2. Do NOT use sliding scale insulin alone without basal coverage—this significantly worsens outcomes 5
  3. Do NOT delay basal insulin when transitioning from IV—this risks ketoacidosis in a patient with zero endogenous insulin 1
  4. Rotate injection sites (abdomen, thigh, deltoid) to prevent lipodystrophy 7

Adjustment Strategy

Titrate doses every 1-2 days based on fasting and pre-meal glucose patterns:

  • If fasting glucose consistently >180 mg/dL: increase 8 AM dose by 2-4 units
  • If pre-dinner glucose consistently >180 mg/dL: increase 8 PM dose by 2-4 units
  • If hypoglycemia occurs: reduce corresponding dose by 10-20%

Long-term insulin requirements may increase 8. Patients without preoperative diabetes paradoxically require more careful management post-pancreatectomy than those with long-standing diabetes, as they lack established patterns 8.

References

Related Questions

For a patient with fasting glucose of 3‑4 mmol/L and post‑meal glucose of 10‑13 mmol/L, is it better to give insulin glargine in the morning?
How should I determine the optimal time of day to administer insulin glargine (Lantus) for a patient?
In a diabetic patient taking Lantus (insulin glargine) 24 units each evening with persistently elevated glucose levels, how should the regimen be adjusted?
In a 47‑year‑old male with type 2 diabetes, weighing 121 kg and currently on insulin glargine (Lantus) 20 U at bedtime, who will receive dexamethasone 10 mg at 8 pm and again at 8 am the following day, what should his insulin glargine dose be for tonight and tomorrow night, and what fixed pre‑meal rapid‑acting insulin doses should be used?
Should I decrease my insulin glargine (Lantus) dose, currently 22 units, given a blood glucose of 219 mg/dL at 2 am and 152 mg/dL at 7 am?
What serum phosphate level defines hyperphosphatemia, and what are the appropriate management steps?
What are the different classes of antibodies and types of antigens, and when do they develop after exposure?
What is the appropriate treatment for facial fungal acne (Malassezia folliculitis)?
How should I manage a serum phosphate of 6 mg/dL in a patient without chronic kidney disease?
What is the recommended terbinafine dosage for treating tinea corporis in adults and children?
Can doxycycline capsules be used as primary treatment for facial fungal acne (Malassezia folliculitis)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.